NCT04394455

Brief Summary

The purpose of this randomized controlled trial is to determine the effect of two behavioral interventions: brief cognitive-behavioral therapy and crisis intervention therapy through telepsychiatry, over the level of perceived stress, anxiety, depression and post-traumatic stress symptoms during the COVID-19 pandemic in medical residents and medical staff at three hospitals in two cities of Honduras.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
236

participants targeted

Target at P75+ for not_applicable anxiety

Timeline
Completed

Started Jun 2020

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2020

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 19, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

June 30, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

July 2, 2020

Status Verified

June 1, 2020

Enrollment Period

5 months

First QC Date

May 3, 2020

Last Update Submit

June 30, 2020

Conditions

Keywords

telepsychiatrycognitive behavioral therapycrisis interventionanxietydepressionpost traumatic stress

Outcome Measures

Primary Outcomes (4)

  • Rate reduction in Depressive symptoms

    Patient Health Questionnaire 9 scale (PHQ-9), a 9 item scale with a score range from 0 to 27. A higher score means a worse outcome.

    6 months after psychotherapeutic intervention has started

  • Rate reduction in Anxiety symptoms

    General Anxiety Disorder 7 Scale (GAD-7), a 7 item scale with a score range from 0 to 21. A higher score means a worse outcome.

    6 months after psychotherapeutic intervention has started

  • Rate reduction in Post traumatic Stress symptoms

    Post-traumatic Stress Scale for DSM-5 (PCL-5), a 20 item scale with a score range from 0 to 80. A higher score means a worse outcome.

    6 months after psychotherapeutic intervention has started

  • Rate reduction in Perceived stress level

    Perceived stress scale (PSS), a 10 item scale with a score range from 0 to 40. A higher score means a worse outcome.

    6 months after psychotherapeutic intervention has started

Study Arms (2)

Brief cognitive behavioral therapy

EXPERIMENTAL

Medical staff (medical doctors and residents) who will receive brief cognitive behavioral therapy through telepsychiatry.

Behavioral: Brief cognitive behavioral therapy

Crisis intervention therapy

ACTIVE COMPARATOR

Medical staff (medical doctors and residents) who will receive 3 sessions of crisis intervention therapy through telepsychiatry.

Behavioral: Crisis intervention therapy

Interventions

9 structured psychotherapy sessions, weekly, 60-90 minutes duration. Provided by one therapist and one co-therapist. Provided through telepsychiatry.

Brief cognitive behavioral therapy

3 structured sessions of crisis intervention. One session each week for three weeks. Provided by one therapist and one co-therapist. Provided through telepsychiatry.

Crisis intervention therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Medical doctors and medical residents 18 years and older, from UNAH medical school and Hospital de Occidente.
  • Medical doctors and medical residents whom during the initial screening show positive scores in Patient Health Questionnaire-2 and Generalized Anxiety Disorder scale-2
  • Access to internet and an electronic device

You may not qualify if:

  • Medical doctors and medical residents referring a history of psychiatric disorders
  • Medical residents that belong to the Psychiatry Residency Program
  • Medical residents and medical doctors that have been diagnosed with COVID-19
  • Medical doctors and residents whom during evaluations show severe symptoms of depression, anxiety and post-traumatic stress symptoms
  • Medical doctors and residents with negative screening in Patient Health Questionnaire-2 and Generalized Anxiety Disorder Scale-2
  • Participants that do not have access to internet connection or an electronic device.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Nacional Autónoma de Honduras

Tegucigalpa, Francisco Morazán Department, 11101, Honduras

Location

MeSH Terms

Conditions

Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • José R Galindo-Donaire, MD

    Universidad Nacional Autonoma de Honduras

    PRINCIPAL INVESTIGATOR
  • Elena N Reyes-Flores, MD

    Universidad Nacional Autonoma de Honduras

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Investigators will not take part in the baseline symptom evaluation of subjects or the post-intervention evaluation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The interventional models are brief cognitive behavioral therapy and crisis intervention therapy through telepsychiatry. Each arm will be divided into therapy groups with a maximum of 10 participants per group. Each therapy session will be directed by a therapist and a co-therapist using a predefined structure for each intervention, with a duration of 60-90 minutes per session.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Resident

Study Record Dates

First Submitted

May 3, 2020

First Posted

May 19, 2020

Study Start

June 30, 2020

Primary Completion

November 30, 2020

Study Completion

December 30, 2020

Last Updated

July 2, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations